Look into my eyes: melanoma risk can be found in the iris
23 January, 2018Queensland researchers have found that freckles and moles appearing on the iris indicate a high risk of melanoma — particularly in people under 40 years of age.
Training the innate immune system to remember past threats
19 January, 2018An international research team has shown how the innate immune system can be trained to 'remember' past threats and respond more robustly to future challenges.
Gene therapy comes of age
17 January, 2018Gene therapy is no longer the future of medicine, but is part of the present-day clinical treatment toolkit.
Nutraceuticals market growing despite regulatory challenges
19 December, 2017Nutraceuticals are expanding into new territories as the need for new therapies increases, according to GBI Research.
Nearly 40% of Australian cancer deaths are potentially preventable
15 December, 2017Queensland researchers have found that 38% of cancer deaths in Australia, or 16,700 each year, could potentially be avoided — mostly through lifestyle changes.
Rare diseases and the power of precision medicine
15 December, 2017 by Mansi GandhiWhen molecular biologists Steve Wilton and Sue Fletcher first started exploring dystrophin exon skipping for Duchenne muscular dystrophy (DMD), they faced a lot of scepticism.
Light-activated glue seals wounds in 60 seconds
14 December, 2017 by Bec CrewAustralian scientists have invented a gel that seals wounds and stops bleeding — both internally and externally — within 60 seconds. It sends signals to the body to start repairing the wound — at twice the regular speed.
Gene editing — one reagent doesn't fit all
13 December, 2017Person-to-person genetic differences may undercut the efficacy of the gene editing process or, in more rare cases, cause a potentially dangerous off-target effect, warn researchers.
Engineering yeast to create protein pharmaceuticals
12 December, 2017Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells.
Tumour-suppressive protein patrols metastatis sites
12 December, 2017Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time.
Patient enrolment for CSL's biggest heart attack trial to begin in early 2018
06 December, 2017Australian-listed global bio-therapeutics company CSL has confirmed a Phase 3 clinical trial for CSL112, the company's novel therapy for reduction of early recurrent cardiovascular events in heart attack survivors.
Nearly 6% of cancers attributable to diabetes, high BMI
06 December, 2017UK researchers have revealed that diabetes and high body-mass index were the cause of 5.6% of new cancer cases worldwide in 2012 — equivalent to 792,600 cases.
LeafCann and WardMM partner for BPSD clinical trial
30 November, 2017LeafCann Research and Advisory has signed a clinical trial agreement with WardMM to sponsor and provide medicinal cannabis extracts for the latter's research and development program for the treatment of behavioural and psychological symptoms of dementia (BPSD).
Griffith Uni celebrates new biobanking resource, MoU with Gold Coast Health
28 November, 2017Griffith University is discussing a number of its recent initiatives as part the Gold Coast Health Research Week Conference.
New TGA rules assist access to medical cannabis
24 November, 2017The TGA has announced changes to its Special Access Scheme that will make it easier for medical practitioners to prescribe cannabis-based medicines for patients in need, under certain conditions.
